Showing posts with label Patents. Show all posts
Showing posts with label Patents. Show all posts

Tuesday, February 02, 2016

New Ideas: How Far is the Market?


What is the distance between a product-idea and the marketplace in India?

In the developed markets this distance has been cut down considerably by those who have an access to the internet. As this article illustrates, the difference between those who harness freelancers on the internet, and those who go the traditional way, can run into thousands of dollars.

Comparing two similar products presented at a trade show, it turned out that one had spent four years and hundreds of thousands of dollars in hiring engineers and manufacturers, while another needed just seven months and $11,800 to get there. How the market responds to a prototype presented at a trade show depends on a number of factors but what does it take to get till this point?

The first thing you need, of course, is an idea. From here on you are seeking the answers to a series of questions:


  • Is the Idea unique?  - checking the online databases at Patent Offices and Patent Depository Libraries. If the idea turns out to be unique, then - 
  • Who provides the best VFM for professional Patents Search services? If the idea continues to have legs, then after filing a provisional patent - 
  • Which product designer / engineer can create a prototype model?
  • How should demand and product pricing be assessed?  - Focus groups through sources like ManagementHelp.org
  • Which manufacturer provides the best deal in terms of cost and quality? Does he also have his own distribution network?

In India, over and above all these questions, you need to also constantly look over your shoulder to see if there is anybody waiting to flood the market with cheap imitations!

-----------------------------------------------------------

* Entrepreneur.com (2010) - From Idea to Market - http://www.entrepreneur.com/article/217332


Thursday, March 19, 2015

IPO - Like a Rock

In the early 1990's when I visited the Indian Patent Office (IPO) for the first time, it was as gloomy and depressing as any other dysfunctional sarkari office. Over the years, it certainly seems to have changed for the better.

Now, at a time when, "advanced industrialised countries are ratcheting up global standards for intellectual property protection with monotonous regularity, keeping in view the interests of the dominant corporate interests" (Biswajit Dhar, FE), our patent office has been standing its ground.

Section 3(d) of Patents Act ensures that rights cannot be obtained for minor innovations, and this is being implemented quite effectively -


  • 2006 - India’s patent office refused to give Novartis AG a patent for Glivec (Imatinib), an extremely effective drug for a rare cancer - CML
  • 2012 - India’s Intellectual Property Appellate Board revoked a Roche Holding AG patent for a hepatitis C drug (Pegasys) saying technology involved in the drug’s invention was “obvious” and could be replicated easily.
  • January 2015 - India’s patent office rejected a patent application from the U.S. biotech firm Gilead Sciences Inc. for a Hepatitis C treatment (Sovaldi) , saying it lacked novelty and didn’t show significant efficacy over previously known compounds.
  • March, 2015 - IPO withdrew patent protection for an emphysema drug (Spiriva) marketed by Germany’s Boehringer Ingelheim GmbH, in response to an objection filed by Cipla.


What (or who) is the driving force behind this transformation of the Indian Patent Office?  What mechanisms do they have in place to ensure that Big Pharma do not get away with Evergreening? And, most importantly, what can the patent office do to improve our own abysmal record in encouraging innovations, and building innovative, world-class products?

Perhaps organisations like the Lawyers Collective had a strong role to play here.

------------------------------------------------
LINKS

* Key Medicines -  Patent Status in India -- http://www.lawyerscollective.org/drugs-list

* http://in.reuters.com/article/2015/01/14/gilead-india-patent-idINKBN0KN20V20150114

* India Patent Office -- http://www.ipindia.nic.in/

* (19Mar15) - WSJ - India's fight against Big Pharma is a Just War -- http://blogs.wsj.com/indiarealtime/2015/03/19/inside-india-indias-fight-against-big-pharma-patents-is-a-just-war/

* Biswajit Dhar (2014): IPR policy must drive innovation -- http://www.macroscan.net/pdfs/ipr_policy.pdf